Marvell, Micron shares tumble as the chip sector suffers its worst day in 6 years

MarketWatch

S&P 500 companies can’t stop talking about higher oil prices. But few say they’ll actually hit profits.

MarketWatch

Tired of nausea or taking a GLP-1 pill every day? These experimental drugs could be better than Zepbound and Wegovy.

MarketWatch

The U.S. stock market is facing historic downside risk — these 10 low-volatility stocks can protect your portfolio

MarketWatch

The blowout jobs report is bad news for stocks — but it shouldn’t force the Fed’s hand on interest rates

MarketWatch

Can SpaceX live up to Wall Street’s multitrillion-dollar hype?

MarketWatch

America’s crude inventories are getting perilously low. But that’s not the full story.

MarketWatch

Apple’s WWDC will be a make-or-break moment for the company’s fledgling AI strategy

MarketWatch

‘He’s very short-tempered’: My husband won’t sell his home so we can combine our finances and live in comfort. Am I unreasonable?

MarketWatch

The key to the upcoming Fed meeting? How Warsh reacts to all the hints of a rate hike.

MarketWatch

S&P 500 sees $1.8 trillion wipeout, Nasdaq tallies biggest point drop on record. Here’s what investors need to know about Friday’s selloff.

MarketWatch

Bitcoin is suffering from an ‘attention’ deficit, as momentum traders have moved on

MarketWatch

First Google, now Meta? Big Tech may increasingly sell stock to bankroll $820 billion AI boom.